Wealthcare Advisory Partners’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-130
Closed -$6K – 637
2021
Q1
$6K Buy
+130
New +$5.35K ﹤0.01% 1579
2020
Q2
– Sell
-130
Closed -$6K – 384
2020
Q1
$6K Hold
130
– – ﹤0.01% 1036
2019
Q4
$6K Hold
130
– – ﹤0.01% 1055
2019
Q3
$5K Hold
130
– – ﹤0.01% 1061
2019
Q2
$6K Hold
130
– – ﹤0.01% 1009
2019
Q1
$5K Hold
130
– – ﹤0.01% 952
2018
Q4
$5K Hold
130
– – ﹤0.01% 916
2018
Q3
$4K Buy
+130
New +$3.8K ﹤0.01% 1016

Other funds holding ATEX

Wealthcare Advisory Partners's ATEX Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Anterix (ATEX) in Q2 2021, closing a stake of 130 shares — an estimated $6K sold.

Wealthcare Advisory Partners first reported a position in ATEX in Q3 2018 and held it in 8 quarters. The position peaked at $6K in Q1 2021. 107 funds tracked by Wall St. Rank hold ATEX as of Q2 2021.

  • Wealthcare Advisory Partners reported no remaining Anterix position as of Q2 2021 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 130 Anterix shares in Q2 2021, an estimated $6K.
  • Wealthcare Advisory Partners first reported a position in Anterix in Q3 2018 and held it in 8 quarters.
  • Wealthcare Advisory Partners's Anterix position peaked at $6K in Q1 2021.
  • 107 funds tracked by Wall St. Rank held Anterix as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.